Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial.
about
Clinical use of aromatase inhibitors: current data and future perspectives.The ultrastructure of the adrenal cortex of the Mongolian gerbil (M. unguiculatus)The functional relationships of mitochondria in the rat adrenal cortex.The potency and clinical efficacy of aromatase inhibitors across the breast cancer continuumThe effect of acetylator phenotype on the disposition of aminoglutethimide.Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial.Involvement of steroids in anti-inflammatory effects of PK11195 in a murine model of pleurisyObservations on the pharmacokinetics of low dose aminoglutethimide in patients with advanced breast cancer.A comparison of the endocrine effects of low dose aminoglutethimide with and without hydrocortisone in postmenopausal breast cancer patients.Adrenocortical lipid hyperplasia induced in rats by aniline. A histologic and electron microscopic study.Influence of anastrozole (Arimidex), a selective, non-steroidal aromatase inhibitor, on in vivo aromatisation and plasma oestrogen levels in postmenopausal women with breast cancer.Treatment of breast cancer with aromatase inhibitors--current status and future prospectsDevelopment and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.Aminoglutethimide: a "side-effect" turned to therapeutic advantageAromatase inhibition 2013: clinical state of the art and questions that remain to be solvedPreservation of androgen secretion during estrogen suppression with aminoglutethimide in the treatment of metastatic breast carcinoma.Additive endocrine therapy for advanced breast cancer - back to the future.Extended Adjuvant Endocrine Therapy in Breast Cancer: Evidence and Update - A Review.Treatment of an adrenal cortical carcinoma with a combination of o,p'-DDD and aminoglutethimideMeasurement of the dynamics of stimulation and inhibition of steroidogenesis in isolated rat adrenal cells by using column perfusion.Aminoglutethimide in the treatment of Cushing's syndrome.Treatment of breast carcinoma with aminoglutethimide.
P2860
Q33730581-966F1A95-8F8D-418E-B2FC-826DF31C098FQ34035988-EAC1B994-7E3C-4090-ACF8-C706336FD1FEQ34106246-EAF8B19F-ADA1-42D0-B26A-0026340947F2Q34592879-2C6FFB01-A002-4F81-9719-880BE8FAD763Q34621865-EB07DFE4-A900-4F84-BCBE-59466E9C2563Q34785202-CD078F88-0700-44AE-9230-D6A23ED594B9Q35609117-F46751A1-521C-42EA-B8CE-640F829CC572Q35992412-41E9F0EF-5DED-4E99-8D46-B60345CB9083Q35992680-819C3B06-F287-4666-814B-A15C753BEEE6Q36101360-6BA16369-3ABF-4148-889E-12C99D3EDEE7Q36138879-07FD7065-6974-4BCB-B1A4-11858B03CF09Q36468107-B7A50BEA-C5E0-4BB5-B64A-351E4788F92FQ36684234-77515C40-7258-4EA8-8A43-DC1C3A062F9AQ36771631-C2527F11-9FFC-49E2-8932-802E4E19C82BQ36946008-A31D4328-1121-4F86-95AD-3A138498244CQ37021182-08CEA7BF-C6D5-4084-A03D-701BA472463BQ37622884-2C39A0DF-7ED3-40FB-A040-F58B7170FC5FQ38933874-4B0BF7EA-3BC9-454D-87FB-805F7262ED92Q41231180-BD152035-4FFD-4AE1-9860-A2085B0EC8C1Q41867156-7C1E8CBE-A82B-49E3-BA2B-4E1BF8399981Q43714640-4A14C9C9-1EFF-41B4-A546-CB3B49995047Q54485703-F7D9FD73-AD87-4669-8671-E08F8844FBFE
P2860
Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial.
description
1967 nî lūn-bûn
@nan
1967年の論文
@ja
1967年学术文章
@wuu
1967年学术文章
@zh-cn
1967年学术文章
@zh-hans
1967年学术文章
@zh-my
1967年学术文章
@zh-sg
1967年學術文章
@yue
1967年學術文章
@zh
1967年學術文章
@zh-hant
name
Aminoglutethimide (Elipten-Cib ...... action and therapeutic trial.
@en
Aminoglutethimide
@nl
type
label
Aminoglutethimide (Elipten-Cib ...... action and therapeutic trial.
@en
Aminoglutethimide
@nl
prefLabel
Aminoglutethimide (Elipten-Cib ...... action and therapeutic trial.
@en
Aminoglutethimide
@nl
P2093
P356
P1476
Aminoglutethimide (Elipten-Cib ...... action and therapeutic trial.
@en
P2093
P304
P356
10.1210/JCEM-27-9-1239
P407
P577
1967-09-01T00:00:00Z